Abuse potential of methylenedioxymethamphetamine (MDMA) and its derivatives in zebrafish: role of serotonin 5HT2-type receptors Read More > June 16, 2016
Letter to the Editor: R-ketamine: a rapid-onset and sustained antidepressant without risk of brain toxicity Read More > June 10, 2016
The current state of research on ayahuasca: A systematic review of human studies assessing psychiatric symptoms, neuropsychological functioning, and neuroimaging Read More > June 10, 2016
Magic mushroom compound is a potential treatment for patients with major depression Read More > June 8, 2016
Potential involvement of serotonergic signaling in ketamine’s antidepressant actions: A critical review Read More > June 2, 2016
Potential involvement of serotonergic signaling in ketamine's antidepressant actions: A critical review Read More > June 2, 2016
Efficacy and safety of oral ketamine versus diclofenac to alleviate mild to moderate depression in chronic pain patients: A double-blind, randomized, controlled trial Read More > June 1, 2016
Using the Theory of Planned Behavior to predict implementation of harm reduction strategies among MDMA/ecstasy users Read More > June 1, 2016
Ibogaine and addiction in the animal model, a systematic review and meta-analysis Read More > May 31, 2016
